Article 285: Rethinking the Role of AHC Clinical Trial Offices

• Academic health centers (AHCs) that led the charge to form centralized clinical trial offices are now rethinking their structure and purpose. Although some institutions have continued expanding their service offerings, others are decentralizing and disbanding the function.

Article 286: Phase IV Market Steams Ahead

• Phase IV studies are the fastest growing segment of clinical spending, reaching nearly $4 billion in 2002. This sweet spot in the market is being actively pursued by CROs and offers unique opportunities for experienced, community-based clinical investigators.

Article 287: CentreStage Europe: A Look at Sweden's Karolinska Institute

• Although best know abroad as the home of the committee responsible for choosing Nobel Prize winners, the Karolinska Institute is also the powerhouse of Sweden's biomedical research efforts.

Article 288: Eye On: Type 2 Diabetes

• CenterWatch has identified a pipeline of 44 drugs in development for type 2 diabetes, including different insulin formulations, lipid-lowering agents, hormone analogs and hypoglycemic.